No Data
Oppenheimer Reiterates Outperform on Kala Bio, Maintains $15 Price Target
Kala Bio Analyst Ratings
Oppenheimer Maintains KALA BIO(KALA.US) With Buy Rating, Announces Target Price $15
Oppenheimer analyst Francois Brisebois maintains $KALA BIO(KALA.US)$ with a buy rating, and sets the target price at $15.According to TipRanks data, the analyst has a success rate of 38.8% and a
KALA BIO to Present at H.C. Wainwright 4th Annual Ophthalmology Virtual Conference
Express News | KALA BIO Inc : H.c. Wainwright Cuts Target Price to $15 From $18
KALA BIO GAAP EPS of -$3.16 Beats by $1.25
No Data
No Data
